Home・Lista de Ações・Medpace Holdings Inc

Medpace Holdings Inc

Abrir

SetorSaúde

579.14 -1.03

Comprar Vender

Visão Geral

Variação de preço das ações

24h

Atual

Mín

565.71

Máximo

592.34

Indicadores-chave
By Trading Economics
Rendimento	-2.5M 121M
Vendas	727K 707M
P/E Médio do Setor	35.334 64.641
EPS	4.25
Margem de lucro	17.158
Funcionários	6,500
EBITDA	-21M 134M

Recomendações
By TipRanks
Recomendações	Neutro
Previsão para 12 meses	-0.81% downside

Dividendos
By Acuity
Próximos Ganhos	21 de out. de 2026

Estatísticas de Mercado
By TradingEconomics
Capitalização de Mercado	1.4B 16B
Abertura anterior	580.17
Fecho anterior	579.14

Sentimento de Notícias

By Acuity

50%

158 / 340 Ranking em Healthcare

Medpace Holdings Inc Gráfico

O desempenho passado não é um indicador confiável de resultados futuros.

Notícias Relacionadas

29 de jul. de 2026, 18:44 UTC

Macro Event

Medpace Holdings Inc. is trading higher, buoyed by the Federal Reserve's steady interest rates, despite broader market pressures from rising oil prices and geopolitical tensions.

28 de jul. de 2026, 23:11 UTC

Medpace Holdings Inc shares are higher in after-market hours, rebounding after four consecutive lower closes and remaining above the 20-day moving average.

27 de jul. de 2026, 16:56 UTC

News

Medpace Holdings Inc. shares are lower amid broader market volatility, despite reporting strong Q2 2026 business awards and raising guidance.

24 de jul. de 2026, 18:26 UTC

News

Analyst upgrades from RBC Capital and Truist Securities boost Medpace Holdings' price targets, contributing to modest gains during Friday's trading session.

22 de jul. de 2026, 23:22 UTC

Social Media

News

Medpace Holdings Inc. reported Q2 revenue of $707.3 million, exceeding expectations, and raised 2026 guidance, driving shares higher in after-market trading.

21 de jul. de 2026, 19:46 UTC

News

Medpace Holdings Inc. shares rise as analysts project 14.3% revenue growth ahead of Wednesday's Q2 earnings report, following a $706.6 million revenue last year.

Comparação entre Pares

Variação de preço

Medpace Holdings Inc Previsão

Preço-alvo

By TipRanks

-0.81% parte inferior

Previsão para 12 meses

Média 580.2 USD -0.81%

Máximo 692 USD

Mínimo 450 USD

Com base em 11 analistas de Wall Street que oferecem metas de preço de 12 meses para Medpace Holdings Inc - Dist nos últimos 3 meses.

Consenso de Avaliação

By TipRanks

Neutro

11 ratings

Comprar

Manter

Vender

Com base em 11 analistas que deram avaliações de ações para Medpace Holdings Inc - Dist nos últimos 3 meses.

Sentimento

By Acuity

158 / 340 Ranking em Saúde

Informação Financeira

Custos administrativos e de venda

Custos Operacionais

Lucro antes de imposto

Vendas

Custo das vendas

Lucro bruto sobre vendas

Despesa com juros da dívida

EBITDA

Resultado Operacional

Sobre Medpace Holdings Inc

Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. The company offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. It provides clinical development services to the pharmaceutical, biotechnology, and medical device industries; and development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support services. In addition, the company offers bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. Medpace Holdings, Inc. was founded in 1992 and is based in Cincinnati, Ohio.